Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies

Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The revision indicator on the page was updated from v3.5.3 to v3.5.4, indicating a newer version of the page's revision or template.
    Difference
    0.0%
    Check dated 2026-05-16T09:09:51.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The site’s page revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor platform/content-system update rather than a change to the underlying trial information.
    Difference
    0.0%
    Check dated 2026-04-24T13:47:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the site metadata.
    Difference
    0.0%
    Check dated 2026-04-17T11:38:50.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T20:31:03.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T19:09:44.000Z thumbnail image
  9. Check
    115 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding lapse notice as well as Revision: v3.4.1 from the page.
    Difference
    0.2%
    Check dated 2026-02-11T06:16:13.000Z thumbnail image

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.